What information contains summary of product characteristic and how to use it? Review article

Main Article Content

Dagmara Mirowska-Guzel

Abstract

Summary of product characteristics is a mandatory document necessary to register medicinal product (medicine), i.e. to allow it to be placed on the market. Medicines accessible in Poland are registered under the procedures applicable in the European system. The article presents the possible registering procedures, content of summary of product characteristics, sources where you can find their current versions and their meaning for the physician – practitioner, with particular emphasis on the drug program (B.29) for the treatment of multiple sclerosis.

Article Details

Section
Articles

References

1. Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych (access: 30.08.2023).
2. Europejska Agencja Leków – European Medicine Agency (access: 30.08.2023).
3. Amerykańska Agencja ds. Żywności i Leków – Food and Drug Administration (access: 30.08.2023).
4. Rejestracja leków w krajach europejskich (access: 30.08.2023).
5. Rejestry medyczne (access: 30.08.2023).
6. Rejestr produktów leczniczych (access: 30.08.2023).
7. European Commission. A guideline on Summary of Product Characteristics (SmPC) 2009 (access: 30.08.2023).
8. Lista programów lekowych (access: 30.08.2023).